^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

MSLN CAR-T

i
Other names: anti-mesothelin gene engineered lymphocytes, anti-mesothelin CAR T cell receptor immunotherapy, MSLN CAR-T, Anti-mesothelin chimeric T cell receptor (CAR) transduced peripheral blood lymphocytes (PBL)
Associations
News
Company:
National Cancer Institute
Drug class:
Mesothelin-targeted CAR-T immunotherapy
Associations
News